Vericel Corp (VCEL)
46.42
+1.02
(+2.25%)
USD |
NASDAQ |
Apr 23, 16:00
46.42
0.00 (0.00%)
After-Hours: 17:15
Vericel Total Liabilities (Quarterly): 127.70M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 127.70M |
| September 30, 2023 | 113.74M |
| June 30, 2023 | 111.78M |
| March 31, 2023 | 71.12M |
| December 31, 2022 | 80.73M |
| September 30, 2022 | 70.18M |
| June 30, 2022 | 70.00M |
| March 31, 2022 | 67.80M |
| December 31, 2021 | 73.24M |
| September 30, 2021 | 67.36M |
| June 30, 2021 | 70.85M |
| March 31, 2021 | 71.26M |
| December 31, 2020 | 71.35M |
| September 30, 2020 | 42.87M |
| June 30, 2020 | 39.10M |
| March 31, 2020 | 39.81M |
| December 31, 2019 | 42.15M |
| September 30, 2019 | 40.54M |
| June 30, 2019 | 37.28M |
| March 31, 2019 | 38.17M |
| December 31, 2018 | 16.46M |
| September 30, 2018 | 29.99M |
| June 30, 2018 | 31.60M |
| March 31, 2018 | 31.47M |
| December 31, 2017 | 32.04M |
| Date | Value |
|---|---|
| September 30, 2017 | 23.54M |
| June 30, 2017 | 22.56M |
| March 31, 2017 | 25.08M |
| December 31, 2016 | 23.89M |
| September 30, 2016 | 16.63M |
| June 30, 2016 | 12.33M |
| March 31, 2016 | 13.83M |
| December 31, 2015 | 12.18M |
| September 30, 2015 | 9.408M |
| June 30, 2015 | 10.98M |
| March 31, 2015 | 12.79M |
| December 31, 2014 | 11.94M |
| September 30, 2014 | 12.60M |
| June 30, 2014 | 17.05M |
| March 31, 2014 | 6.109M |
| December 31, 2013 | 5.321M |
| September 30, 2013 | 7.252M |
| June 30, 2013 | 3.842M |
| March 31, 2013 | 4.278M |
| December 31, 2012 | 5.665M |
| September 30, 2012 | 47.35M |
| June 30, 2012 | 51.15M |
| March 31, 2012 | 60.39M |
| December 31, 2011 | 20.71M |
| September 30, 2011 | 25.23M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
37.28M
Minimum
Jun 2019
127.70M
Maximum
Dec 2023
68.89M
Average
70.18M
Median
Sep 2022
Total Liabilities (Quarterly) Benchmarks
| Arbutus Biopharma Corp | 38.38M |
| Chimerix Inc | 19.74M |
| Karyopharm Therapeutics Inc | 376.64M |
| Axsome Therapeutics Inc | 397.26M |
| Y-mAbs Therapeutics Inc | 26.88M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 353.66M |
| Shareholders Equity (Quarterly) | 225.95M |
| Current Ratio | 4.495 |